Pre-market hot trades in US stocks: Top Kingwin up 7.34% pre-market; Triller up 7.16% pre-market

Pre-market Hot Trades in US Stocks Top Kingwin, up 7.34% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Triller, up 7.16% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Top Gainers in Pre-market US Stocks Mobile-Health Network Solutions, up 40.00% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. A PARADISE ACQUISITION CORP COM NPV(SUB RTS) 29/07/2025, up 35.01% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. SciSparc up 33.20% in pre-market trading. Based on recent key news: On November 26, SciSparc announced the acquisition of a patent and intellectual property portfolio from Xylo Technologies, including the MUSE system for treating gastroesophageal reflux disease. This transaction will give Xylo a 19.99% equity stake or pre-funded warrants in SciSparc. This news drove SciSparc's stock price up 36.11%. Source: Reuters On November 26, SciSparc plans to replicate Xylo's commercialization model in China across North America, Europe, and Latin America. This strategic expansion plan has enhanced market confidence in the company's future growth, further driving up the stock price. Source: Reuters On November 26, SciSparc's stock price has fallen about 68% over the past year, and this acquisition and expansion plan is seen as a positive signal for the company's recovery, attracting investor attention. Source: Reuters The innovation in the pharmaceutical industry drives market interest